MedTrace Logo

Clinical Efficacies of Different Agents in Molar-Incisor Hypomineralization

NCT06180369 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-12-22

No results posted yet for this study

Summary

This study aims to assess the clinical effectiveness of GC Fuji Triage ® (GC America Inc., Alsip, Illinois) and BeutiSealant (Shofu, Kyoto, Japan) in children aged 8-13 with multiple molars affected by Molar-Incisor Hypomineralization (MIH). The comparison focuses on permanent first molars affected by MIH.

Conditions

  • Molar-Incisor Hypomineralization

Interventions

OTHER

GC Fuji Triage ® GC America Inc., Alsip, Illinois )

Fissur Sealent application

OTHER

BeutiSealant (Shofu, Kyoto, Japonya)

Fissur Sealent application

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2024-12-31
Completion
2025-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180369 on ClinicalTrials.gov